Bellevue Group AG continued to hold its position in Envision Healthcare Corporation (NYSE:EVHC) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,026 shares of the company’s stock at the end of the first quarter. Bellevue Group AG’s holdings in Envision Healthcare Corporation were worth $799,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Livforsakringsbolaget Skandia Omsesidigt bought a new position in Envision Healthcare Corporation during the first quarter valued at approximately $135,000. Korea Investment CORP purchased a new position in Envision Healthcare Corporation during the first quarter worth $141,000. Ameritas Investment Partners Inc. purchased a new position in Envision Healthcare Corporation during the first quarter worth $172,000. First Interstate Bank bought a new position in Envision Healthcare Corporation during the first quarter worth approximately $184,000. Finally, Elkfork Partners LLC acquired a new stake in Envision Healthcare Corporation during the fourth quarter worth $192,000. 67.47% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Envision Healthcare Corporation (NYSE EVHC) traded up 0.71% during midday trading on Friday, reaching $58.12. The company had a trading volume of 734,710 shares. The firm’s 50-day moving average price is $56.22 and its 200 day moving average price is $63.27. The firm’s market capitalization is $6.75 billion. Envision Healthcare Corporation has a 12 month low of $53.12 and a 12 month high of $81.26.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, May 2nd. The company reported $0.69 EPS for the quarter, hitting analysts’ consensus estimates of $0.69. Envision Healthcare Corporation had a positive return on equity of 5.75% and a negative net margin of 9.16%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $2.52 billion. Equities analysts anticipate that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Bellevue Group AG Holds Position in Envision Healthcare Corporation (EVHC)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/06/16/envision-healthcare-co-evhc-position-held-by-bellevue-group-ag-updated-updated.html.

Several analysts have commented on EVHC shares. Royal Bank of Canada decreased their price target on shares of Envision Healthcare Corporation from $87.00 to $80.00 and set an “outperform” rating for the company in a research report on Wednesday, March 1st. Jefferies Group LLC reissued a “buy” rating and set a $82.00 price target (down from $90.00) on shares of Envision Healthcare Corporation in a research report on Wednesday, March 1st. Zacks Investment Research downgraded shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, March 7th. TheStreet downgraded shares of Envision Healthcare Corporation from a “b-” rating to a “c+” rating in a report on Thursday, March 9th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Envision Healthcare Corporation in a report on Thursday, March 16th. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $72.00.

In other Envision Healthcare Corporation news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $61.34, for a total transaction of $92,010.00. Following the transaction, the insider now owns 115,863 shares of the company’s stock, valued at approximately $7,107,036.42. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 3.10% of the company’s stock.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.